Cargando…

REV7 is required for processing AID initiated DNA lesions in activated B cells

Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dingpeng, Sun, Ying, Chen, Jingjing, Zhang, Ying, Fan, Shuangshuang, Huang, Min, Xie, Xia, Cai, Yanni, Shang, Yafang, Gui, Tuantuan, Sun, Liming, Hu, Jiazhi, Dong, Junchao, Yeap, Leng-Siew, Wang, Xiaoming, Xiao, Wei, Meng, Fei-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272641/
https://www.ncbi.nlm.nih.gov/pubmed/32499490
http://dx.doi.org/10.1038/s41467-020-16632-8
_version_ 1783542297695092736
author Yang, Dingpeng
Sun, Ying
Chen, Jingjing
Zhang, Ying
Fan, Shuangshuang
Huang, Min
Xie, Xia
Cai, Yanni
Shang, Yafang
Gui, Tuantuan
Sun, Liming
Hu, Jiazhi
Dong, Junchao
Yeap, Leng-Siew
Wang, Xiaoming
Xiao, Wei
Meng, Fei-Long
author_facet Yang, Dingpeng
Sun, Ying
Chen, Jingjing
Zhang, Ying
Fan, Shuangshuang
Huang, Min
Xie, Xia
Cai, Yanni
Shang, Yafang
Gui, Tuantuan
Sun, Liming
Hu, Jiazhi
Dong, Junchao
Yeap, Leng-Siew
Wang, Xiaoming
Xiao, Wei
Meng, Fei-Long
author_sort Yang, Dingpeng
collection PubMed
description Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutations in SHM. REV7, a component of TLS polymerase zeta, is also a downstream effector of 53BP1-RIF1 DSBR pathway. Here, we study the multi-functions of REV7 and find that REV7 is required for the B cell survival upon AID-deamination, which is independent of its roles in DSBR, G2/M transition or REV1-mediated TLS. The cell death in REV7-deficient activated B cells can be fully rescued by AID-deficiency in vivo. We further identify that REV7-depedent TLS across UNG-processed apurinic/apyrimidinic sites is required for cell survival upon AID/APOBEC deamination. This study dissects the multiple roles of Rev7 in antibody diversification, and discovers that TLS is not only required for sequence diversification but also B cell survival upon AID-initiated lesions.
format Online
Article
Text
id pubmed-7272641
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72726412020-06-15 REV7 is required for processing AID initiated DNA lesions in activated B cells Yang, Dingpeng Sun, Ying Chen, Jingjing Zhang, Ying Fan, Shuangshuang Huang, Min Xie, Xia Cai, Yanni Shang, Yafang Gui, Tuantuan Sun, Liming Hu, Jiazhi Dong, Junchao Yeap, Leng-Siew Wang, Xiaoming Xiao, Wei Meng, Fei-Long Nat Commun Article Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutations in SHM. REV7, a component of TLS polymerase zeta, is also a downstream effector of 53BP1-RIF1 DSBR pathway. Here, we study the multi-functions of REV7 and find that REV7 is required for the B cell survival upon AID-deamination, which is independent of its roles in DSBR, G2/M transition or REV1-mediated TLS. The cell death in REV7-deficient activated B cells can be fully rescued by AID-deficiency in vivo. We further identify that REV7-depedent TLS across UNG-processed apurinic/apyrimidinic sites is required for cell survival upon AID/APOBEC deamination. This study dissects the multiple roles of Rev7 in antibody diversification, and discovers that TLS is not only required for sequence diversification but also B cell survival upon AID-initiated lesions. Nature Publishing Group UK 2020-06-04 /pmc/articles/PMC7272641/ /pubmed/32499490 http://dx.doi.org/10.1038/s41467-020-16632-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Yang, Dingpeng
Sun, Ying
Chen, Jingjing
Zhang, Ying
Fan, Shuangshuang
Huang, Min
Xie, Xia
Cai, Yanni
Shang, Yafang
Gui, Tuantuan
Sun, Liming
Hu, Jiazhi
Dong, Junchao
Yeap, Leng-Siew
Wang, Xiaoming
Xiao, Wei
Meng, Fei-Long
REV7 is required for processing AID initiated DNA lesions in activated B cells
title REV7 is required for processing AID initiated DNA lesions in activated B cells
title_full REV7 is required for processing AID initiated DNA lesions in activated B cells
title_fullStr REV7 is required for processing AID initiated DNA lesions in activated B cells
title_full_unstemmed REV7 is required for processing AID initiated DNA lesions in activated B cells
title_short REV7 is required for processing AID initiated DNA lesions in activated B cells
title_sort rev7 is required for processing aid initiated dna lesions in activated b cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272641/
https://www.ncbi.nlm.nih.gov/pubmed/32499490
http://dx.doi.org/10.1038/s41467-020-16632-8
work_keys_str_mv AT yangdingpeng rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT sunying rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT chenjingjing rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT zhangying rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT fanshuangshuang rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT huangmin rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT xiexia rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT caiyanni rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT shangyafang rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT guituantuan rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT sunliming rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT hujiazhi rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT dongjunchao rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT yeaplengsiew rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT wangxiaoming rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT xiaowei rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells
AT mengfeilong rev7isrequiredforprocessingaidinitiateddnalesionsinactivatedbcells